Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients
Clinical trial NCT06657859 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06657859
- Sponsor
- Glycomine, Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2029-09-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.